LeMaitre Vascular
LMAT • NASDAQ
LeMaitre Vascular is a medical - instruments & supplies company in the healthcare sector trading on NASDAQ, led by CEO George W. LeMaitre, with a market cap of $2.4B.
CEOGeorge W. LeMaitre
Next Earnings
Upcoming earnings announcement for LeMaitre Vascular
Date
Thursday, April 30, 2026 (in 4 weeks)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
$0.66
Revenue Estimate
$66.6M
Earnings History
Past 12 earnings reports for LeMaitre Vascular
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 25, 2026 | Q4 2025 | $0.68Est: $0.67 | +1.5% | $64.5MEst: $62.9M | +2.5% |  10-K |
| Nov 6, 2025 | Q3 2025 | $0.75Est: $0.57 | +31.6% | $61.0MEst: $62.3M | -1.9% | 10-Q |
| Aug 5, 2025 | Q2 2025 | $0.60Est: $0.57 | +5.3% | $64.2MEst: $62.6M | +2.7% | 10-Q |
| May 1, 2025 | Q1 2025 | $0.48Est: $0.50 | -4.0% | $59.9MEst: $57.6M | +3.9% | 10-Q |
| Feb 27, 2025 | Q4 2024 | $0.49Est: $0.49 | 0.0% | $55.7MEst: $56.0M | -0.5% | 10-K |
| Oct 31, 2024 | Q3 2024 | $0.49Est: $0.43 | +14.0% | $54.8MEst: $53.5M | +2.5% | 10-Q |
| Aug 1, 2024 | Q2 2024 | $0.53Est: $0.47 | +12.8% | $55.8MEst: $55.0M | +1.6% | 10-Q |
| May 2, 2024 | Q1 2024 | $0.44Est: $0.39 | +12.8% | $53.5MEst: $51.5M | +3.8% | 10-Q |
| Feb 27, 2024 | Q4 2023 | $0.38Est: $0.36 | +5.6% | $48.9MEst: $49.0M | -0.3% | 10-K |
| Nov 1, 2023 | Q3 2023 | $0.33Est: $0.30 | +10.0% | $47.4MEst: $47.6M | -0.4% | — |
| Aug 1, 2023 | Q2 2023 | $0.37Est: $0.32 | +15.6% | $50.1MEst: $48.3M | +3.8% | 10-Q |
| May 2, 2023 | Q1 2023 | $0.27Est: $0.25 | +8.0% | $47.1MEst: $43.5M | +8.1% | — |